SLC16A1 and neoplasm: HIF-dependent and HIF-nondependent pathways, both of which involve include Monocarboxylate Transporter 1 (MCT1)-mediated lactate import and subsequent inhibition of Prolyl Hydroxylase (PHD), increase tumor-derived lactate-induced endothelial cell activation and angiogenesis (41, 42).